13 Slingluff CL, Petroni GR, Yamshchikov GV, et al. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte- macrophage colony- stimulating factor in adjuvant or pulsed on dendritic cells. J Clin Oncol 2003;21:4016–26. 14 Slingluff CL, Petroni GR, Chianese- Bullock KA, et al. Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting. Clin Cancer Res 2007;13:6386–95. 15 Slingluff CL, Petroni GR, Olson WC, et al. Effect of granulocyte/ macrophage colony- stimulating factor on circulating CD8+ and CD4+ T- cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial. Clin Cancer Res 2009;15:7036–44. 16 Slingluff CL, Petroni GR, Olson W, et al. Helper T- cell responses and clinical activity of a melanoma vaccine with multiple peptides from MAGE and melanocytic differentiation antigens. J Clin Oncol 2008;26:4973–80.